Search

everythinglearnresearchcommunity

for

Search:↓

The conversation discusses skepticism about new hair loss treatments, with many users expressing doubt about the effectiveness and availability of future solutions. Current treatments like minoxidil, finasteride, and hair transplants are mentioned as reliable options.

Cosmo Pharma plans to release Breezula, a hair loss treatment, with expected FDA approval in 2027, but concerns arise over its high potential cost of $225/month. Users express skepticism about its effectiveness compared to cheaper alternatives like finasteride and minoxidil.

PP405, a promising hair loss treatment, is expected to be available by 2027, with faster trials due to its topical nature. Users are eager for its release, comparing it to existing treatments like minoxidil and finasteride, but remain cautious about its long-term effectiveness.

Switching to Dutasteride worsened hair condition, causing shedding and inflammation. The user will continue Dutasteride until 18 months before possibly switching back to Finasteride, while using oral Minoxidil.

The conversation discusses hair loss treatments, specifically the use of oral finasteride and topical minoxidil, with the user sharing their two-year progress and routine. The user experienced initial shedding but saw improvements after six months, and they recently started taking dutasteride.

Recruitment for a verteporfin trial and a separate hair cloning trial using verteporfin and other methods is underway, with locations in Jordan, NYC, Beverly Hills, and Memphis. Dr. Bloxham is conducting the hair cloning trial, and interested participants are encouraged to contact him directly.

The user experienced significant hair regrowth in 5 weeks using Minoxidil, Finasteride, Dutasteride, biotin, collagen, derma stamping, and a mixture of oils, leading others to label them a "hyper responder." Some users advised caution with microneedling frequency to avoid potential scarring.

The user has been using 0.5 mg dutasteride and 5 mg oral minoxidil for 9 months and has started experiencing hair shedding, losing 70-80 hairs per day. They noticed good density in the crown area within the first month of treatment.

The conversation is about hair loss treatments, specifically oral finasteride (1.2mg) and oral minoxidil (3mg), and the user's concern about increased shedding and brittle hair after 7 months of use. It is suggested that shedding is common and may be influenced by stress, and switching to dutasteride might help, but patience is advised as results can take up to a year.

The user is using 5% topical minoxidil, tretinoin 0.05% cream, and weekly derma rolling for early-stage male pattern baldness and has seen some progress. They prefer not to use finasteride or dutasteride due to potential side effects.

The user experienced significant hair improvement with minoxidil and finasteride but later faced shedding and diffused thinning after developing seborrheic dermatitis. They are seeking advice after trying treatments like ketoconazole, coal tar shampoos, fluconazole, and hydrocortisone cream.

Finasteride can cause initial hair shedding as part of its cycle, but it can also lead to hair regrowth and thickening over time. Users discuss the effectiveness of finasteride alone, with some considering adding minoxidil or switching to dutasteride for better results.

A user shared their hair loss treatment journey, using topical Minoxidil, Finasteride, Tretinoin, and Stemoxydine, and asked for feedback on progress after one month. Responses varied, with some users suggesting patience and consistency, while others noted minimal visible change.

People are discussing JXL-069 (PP405) for hair loss, with some experimenting with a 0.05% topical gel. Concerns about safety and efficacy persist due to limited testing and lack of official approval.

Topical sodium valproate may promote hair growth by inhibiting GSK3β, allowing beta-catenin to proliferate, but it has potential side effects and requires more research. The conversation also mentions skepticism about a product called Vdphlo1, which includes sodium valproate and other ingredients.

VDPHL-01 is essentially a slow-release oral minoxidil, which is already known to work for hair growth. The formulation includes other ingredients like Medrogestone, Valproic acid, Setipiprant, and Cetirizine, but their effectiveness and necessity are questioned.

PP-405, a potential hair loss treatment, shows promise in stimulating dormant hair follicles and may help with various hair loss types. Current treatments like Minoxidil are still recommended as PP-405 is in early trials and may take years to become available.

GT20029 and pyrilutamide are both androgen antagonists but work differently; GT20029 degrades the androgen receptor, while pyrilutamide blocks DHT from binding. GT20029 is expected to have similar efficacy to CosmeRNA.

Combining stemoxydine with topical minoxidil for hair loss treatment. Users discuss application order and effectiveness, with some skepticism about stemoxydine's benefits.

The conversation discusses using topical finasteride (0.25% gel) and minoxidil (5% foam) for hair loss, with users sharing experiences about application methods, microneedling, and results. Some users have switched to oral finasteride for convenience and cost-effectiveness, while others discuss the greasy nature of the topical solution.

A user discussed their hair transplant progress and mentioned using 1mg Finasteride, 5% Topical Minoxidil, and recently starting 5% RU58841. They are seeking advice on whether to use RU58841 at month 4 post-transplant.

The user reports losing a significant amount of hair when applying RU58841 and Minoxidil but loses much less hair when massaging or brushing without these treatments. They are concerned about the increased hair loss associated with these products.

User used finasteride and minoxidil for hair loss, experienced side effects initially, but saw improvement after stopping minoxidil and ignoring side effects. New hairstyle also improved hair appearance.

The user reports seeing hair regrowth progress after using finasteride for 5.5 months and minoxidil for 2.5 months, sharing before and after photos. Replies include congratulations and encouragement.

User shared 2.5-year progress using finasteride for hair loss, showing significant improvement and reduced hair shedding. Persistence with finasteride led to thicker hair and fewer hair fall issues.

User shared 3-month progress using Minoxidil 5% and Finasteride 0.1%, switching brands after the first month. Replies suggest the progress is good, with concerns about patches and shedding.

Hair loss treatments vary greatly in effectiveness and timelines, with no guaranteed results. Common treatments mentioned include finasteride, minoxidil, and RU58841.

A 25-year-old man has been using topical minoxidil 5%, oral finasteride 1mg, and microneedling for hair loss treatment for 14, 9, and 8 weeks respectively. He experienced watery semen after starting finasteride, but it normalized after a few days with no other side effects.

Topical Vitamin D3 may stimulate hair growth and has been used for Alopecia Areata. There is a question about the lack of research on its use for Androgenetic Alopecia (AGA).

The conversation is about optimism for new hair loss treatments like Stemson's bioengineering, osteopotin, SCUBE3, GT20029, and Verteprofin, and inquires about other notable treatments.